Dr. Reddy's Laboratories denies rumors of a 25% workforce cost reduction, calling the reports 'factually incorrect'. The company emphasizes its commitment to regulatory disclosures...
KKR, through Tau Investment Holdings, is selling a 10.2% stake in JB Chemicals for Rs 2,575 crore via block deals, at a 5% discount to the market price. This move could mark a sign...
Aurobindo Pharma's subsidiary, Auro Vaccines Pvt Ltd, has terminated its licensing agreement with Hilleman Laboratories for a pediatric pentavalent vaccine. The termination, effect...
Bayer AG's stock rose 4.7% after announcing Q4 2024 earnings exceeding expectations, with €1.9 billion EBITDA and €11.7 billion sales. Despite a tough 2025 forecast, the company an...
Walgreens Boots Alliance Inc. may undergo a significant transformation with a potential buyout by Sycamore Partners, leading to a strategic split into three main businesses: Walgre...
Pfizer projects its 2025 revenue to reach up to $64 billion, with steady COVID-19 product sales and anticipated operational growth of 10% to 18% year-over-year.
